// Welcome Note

The 4th International Human Gene Therapy Conference

We are delighted to invite you to participate in the 4th International Human Gene Therapy Conference 2027, a premier Gene Therapy Conference in Boston, USA, and a globally recognized international event dedicated to human gene therapy. This prestigious Cell and Gene Therapy Conference serves as a leading platform for sharing groundbreaking developments in human gene therapy, genome editing technologies, and cell and gene therapy innovations, along with the latest insights shaping gene therapy research worldwide.

Recognized as a key Gene Therapy Forum 2027, the event will highlight advances in gene therapy research, cell and gene therapy innovation, and emerging next-generation therapeutics that are reshaping modern healthcare. The conference will also explore cutting-edge topics, including CRISPR gene therapy, viral vector manufacturing, AAV gene therapy development, advanced biologics, and regenerative medicine, reflecting the latest trends and developments in the field.

As the field of gene therapy continues to accelerate, the 4th International Human Gene Therapy Conference 2027 brings together experts in biomedical science, clinical research, biotechnology, pharmaceutical development, and regulatory affairs. Attendees will include leading scientists, clinicians, biotech entrepreneurs, policymakers, and industry stakeholders, creating an international platform in Boston, USA, focused on collaboration, innovation, and the advancement of gene therapy research.

Explore the Future of Gene and Cell Therapies

Gene therapy holds the promise of treating—and potentially curing—a wide range of genetic and acquired conditions once considered incurable. From monogenic disorders such as sickle cell disease and hemophilia to complex diseases, including cancers and neurodegenerative disorders, clinical gene therapy advancements are rapidly transforming patient care and advancing medical research worldwide.

This Advanced Therapies Conference USA will showcase progress in precision medicine, translational medicine, and regenerative approaches that bridge scientific discovery with real-world clinical applications. Through expert-led discussions, scientific presentations, and collaborative networking opportunities, participants will gain insights into the evolving landscape of genome editing, innovative cell and gene therapy platforms, and the future of personalized healthcare.

Join global leaders at this premier international gene therapy conference and explore how innovation in cell and gene therapy is shaping the next era of medicine, while gaining insights into the latest research, emerging technologies, and clinical developments in the field.

Invitation to Participate in the 4th International Human Gene Therapy Conference 2027

We are pleased to invite you to attend the 4th International Human Gene Therapy Conference 2027, which will take place from Boston,USA. This distinguished global event is designed to bring together a diverse and interdisciplinary group of experts, including pioneering scientists, clinical researchers, biotech professionals, early-career investigators, and students from around the world.

The conference serves as a vibrant platform to foster collaboration, exchange knowledge, and showcase the most recent advances in gene therapy, genome editing, and cell-based therapeutics. It aims to highlight the transformative potential of gene therapy in treating genetic and acquired diseases and to explore the clinical, scientific, regulatory, and commercial developments driving the field forward.

Attendees will benefit from an engaging program that includes keynote lectures by internationally recognized leaders, thematic technical sessions, poster presentations, and ample opportunities for professional networking. Topics will span a wide range of areas, including CRISPR and gene editing technologies, viral and non-viral vectors, therapeutic gene delivery, clinical trial outcomes, and ethical and regulatory perspectives.

Featured Speakers

Anne Douar

Chief Operating Officer, Vivet Therapeutics, France

Cellia Habita

Biotech Senior Executive, Expert in Drug Development & Clinical Development Operations, France

James L Drinkwater

Ex-Chairman Honorary Member of PHSS, Head of GMP Compliance, Franz Ziel GmbH, United Kingdom

Jeff Chaffin

Principal
Miles Payer Consulting, USA

Larry Forman

Founder & CEO
CHO Plus, USA

Mitra Tavakkoli

Clinical Development Physician and Senior Biotech Consultant, USA

Natasha Paterson

Executive Director Medical Affairs, Tenaya Therapeutics, USA

Olivier Negre

Chief Scientific Officer, Smart Immune, France

Sophie Blondel

Consultant and Cell and Gene Therapies Expert, France

Tristan Jervis

Founder and Managing Director, Impact Shine Communications, UK

// SCIENTIFIC SESSION

Key Topics

Re-Engineering and Rewriting Genetics with Gene therapy: Past, Present & Future Approaches

Gene Therapy Development and Methods
Gene Drug Delivery and Recent Gene Editing Technologies
Gene Therapy R&D Acceleration by AI
Gene Therapy Successes and Ongoing Research
DNA & RNA based Technologies
Gene Therapy Clinical Trials and Patient Engagement

Resetting the Genetic Button: Quality and Regulatory Requirements

Benefits, Risks and Applications of Gene Therapy
Gene Therapy Regulatory Landscape
Safety, Efficacy, Risk Management and Pharmacovigilance in CGT
Ethical and Societal Considerations
Worldwide Approved and Successfully Running CGTs
Quality Assurance and Quality Control
GLP, GMP Compliances

Unlocking Health Mysteries: Analytics, Manufacturing and Commercialization Strategies

Analytical Process Development and Scale-Up Technologies
Market Analysis, Trends and Opportunities
Logistics, Supply Chain, Cost Optimization and Affordability
Pricing Strategies, Market Access, Commercialization and Reimbursement IPR's and Licensing
Investments, Partnerships and Fundings on Global Scale
Success Stories from Research Lab to Market

Gene Therapeutics: Clinical Approaches and Applications

CGT Approaches for Cancer Treatment
Combination of Gene and Cellular Immunotherapies
CGT Approaches for HIV-AIDS, Pulmonary Disorders, Sickle Cell Anaemia, Cystic Fibrosis, Alpha-1 Antitrypsin Deficiency, Haemophilia, Beta thalassemia, Diabetes
Gene therapy for Ophthalmic and Muscular Disorders
Gene Therapy for Neurodegenerative and Rare disorders
Bio Revolution Uniting 3D Bioprinting and Gene Therapy for Tomorrow's Healthcare
Emerging Therapies for Genetic Disorders
Navigating Next by NGS Technology

Who will Attend Gene Forum Conference?

Directors, CEOs of Organizations
Researchers and Scientists
Healthcare Professionals
Industry Professionals
Policy Makers and Government Officials
Non-Governmental Organizations (NGOs) and International Organizations
Students and Early Career Professionals
Investors and Financial Analysts

Media and Communication Professionals
Technology and Innovation Experts
Vice Presidents/Senior Vice Presidents/Executive Vice Presidents
Deans/Senior Professors/Associate Professor/Assistant Professors
Business Entrepreneurs
Medical Devices Manufacturing Companies
Vaccine Developers and Investigators

Why Attend the Gene Therapy Conference

1. Access to Cutting-Edge Research

Stay informed about the latest advancements in gene therapy, including novel gene editing technologies and personalized medicine strategies, directly from leading experts.

2. Expert Keynote Speakers

Gain valuable insights from renowned professionals who will present pioneering research, breakthroughs, and innovative methodologies in gene therapy.

3. Diverse Range of Topics

Participate in a comprehensive program that covers various aspects of gene therapy, including genetic disorders, delivery systems, and regulatory challenges.

4. Interactive Panel Discussions

Engage in dynamic discussions with thought leaders and fellow attendees on complex topics, fostering dialogue and enhancing collaborative problem-solving.

5. Networking Opportunities

Connect with top scientists, researchers, healthcare professionals, and industry leaders from around the world, expanding your professional network.

6. Collaboration and Partnerships

Discover opportunities to collaborate and build partnerships that could lead to impactful research, clinical trials, and career growth in the field of gene therapy.

7. Embrace Technological Advancements

Gain insights into the latest technologies transforming gene therapy, including CRISPR, RNA therapies, and AI-driven gene therapy innovations.

8. Shape the Future of Medicine

Be part of discussions on the next generation of gene therapies for a wide range of conditions, helping to shape the future of medicine and patient care.

Highlighting Your Achievements

Media Partners

Previous Testimonials

"It was a pleasure ! Happy to continue contributing in future meetings."

Daya Verma

Former Director, Program and Portfolio Management, Novartis Pharmaceuticals Corporation, USA

" The speakers were of high quality, bringing a strong mix of industry and academic perspectives across preclinical, clinical, and CMC topics. The networking sessions were excellent, making the event well-organized and valuable overall. I look forward to future editions and would be happy to participate again."

Kok-Seong Lim

Independent Consultant

"I enjoyed the conference very much and thank you for your hard work in organizing this great event. Looking forward to the future edition of the conference."

Wai Lydia Tai, PhD

Schepens Eye Research Institute of Massachusetts Eye and Ear ,Department of Ophthalmology, Harvard Medical School., USA

"Hi ,The conference was great - you had some excellent speakers that provided penetrating analysis - with high quality scientific and data and industry analysis displayed and discussed by articulate speakers."

Tristan Jervis

Founder and Managing Director, Impact Shine Communications, UK

"I was honored to be there, and I really had a great time, and I met a lot of professionals. The conference was very well organized."

Deyaa Shaheen

Founder, XFDA PHARMA ADVISORS CONSULTANTING SERVICES, USA

"Thanks , the conference was nice, I got a lot out of it "

Nermin Ibreljic

Principal Engineer, Gene Therapy, Sarepta Therapeutics, USA

"The talks that I was able to attend were quite enlightening .. And exposure to the various companies/ attendees may be quite useful for networking and furthering our experiments."

Volney L. Sheen, MD, PhD

Associate Professor of Neurology, Harvard Medical School, USA

"Thank you very much for your kind message and for the opportunity to participate in the Gene Therapy Forum 2027. It was a pleasure attending the event in Boston. I truly appreciated the high-quality scientific discussions, excellent organization, and the valuable interactions throughout the meeting.
Thank you again for hosting such a meaningful conference. I look forward to joining future Gene Therapy Forum events and meeting you in person."

José Vázquez

c-LEcta GmbH, Germany

"Thank you for the opportunity. The event was well organized and informative."

Anita Mardian

Vice President,Unit Head,Parexel, USA

"I liked the smaller set-up for the conference—keeping it under 100 attendees is great for fostering discussion and allowing time to connect with speakers after their talks. The venue was good, and the food and catering were well organized."

Patrick Starremans

Head of Analytical Sciences,Solid Biosciences Inc., USA

“It was a great opportunity to present and attend the Gene Therapy Forum 2027. I was impressed by the strong panel of speakers from both industry and academia, covering current advances, challenges, and opportunities in cell and gene therapy. The discussions were insightful and well-structured, offering valuable takeaways and paving the way for broader global collaboration in future meetings.”